{"id":7085990772888,"title":"Sinopharm - Single use hypodermic syringe and needle (for a la carte vaccine products)","handle":"sinopharm-single-use-hypodermic-syringe-and-needle-for-a-la-carte-vaccine-products","description":"\u003cul\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eProduct ID\u003c\/b\u003e: VC.25.2\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLead Time (from Signed Agreement):\u003c\/strong\u003e 30 days. \u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMinimum Order Quantity\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e- 500,000. \u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRegulatory approval:\u003c\/strong\u003e\u003cspan\u003e WHO PQS\u003c\/span\u003e, CE Mark\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAuto disable feature:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eYes\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeedle Length:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e25 mm\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeedle Gauge:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e25g\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSyringe Volume:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e1 ml\/1cc\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSterile:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eYes\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLow dead space:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eYes\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuantity per box\u003c\/strong\u003e: 100\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrice:\u003c\/strong\u003e per syringe\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\u003c\/ul\u003e\n\u003c!-- TABS --\u003e\n\u003ch5\u003eProduct Details\u003c\/h5\u003e\n\u003ch6\u003eInspection\u003c\/h6\u003e\n\u003cp\u003eA factory audit and final random inspection and testing of finished products will be performed by a Bank nominated independent inspection agency. The inspection contract will be let by Sinopharm to the approved inspection agency with costs passed through to the Borrower to pay.\u003c\/p\u003e\n\u003ch6\u003e\u003c\/h6\u003e\n\u003ch5\u003eAbout \u0026amp; Contact\u003cbr\u003e\n\u003c\/h5\u003e\n\u003ch6\u003e\u003c\/h6\u003e\n\u003cp\u003e\u003cspan data-contrast=\"none\" class=\"TextRun BCX9 SCXW139326093\" lang=\"EN-NZ\" xml:lang=\"EN-NZ\"\u003e\u003cspan class=\"NormalTextRun BCX9 SCXW139326093\"\u003e\u003cspan\u003eChina National Pharmaceutical Group Co., Ltd. (Sinopharm) is a large healthcare group directly under the State-owned Assets Supervision and Administration Commission (SASAC) of the State Council, with 128,000 employees and a full chain in the industry covering R\u0026amp;D, manufacturing, logistics and distribution, retail chains, healthcare, engineering services, exhibitions and conferences, international business and financial services.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eFor further enquiries, please contact \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eJade Zhang\u003c\/strong\u003e\u003cbr data-mce-fragment=\"1\"\u003e\u003cspan data-mce-fragment=\"1\"\u003eSinopharm Fortune International Trading Corp.\u003c\/span\u003e\u003cbr data-mce-fragment=\"1\"\u003eAddress: Fortune Tower, No.4, Hui Xin Dongjie, Chao Yang District, Beijing 100029, China\u003cbr data-mce-fragment=\"1\"\u003eTel.: +86-10-8466 3076\/ +86-13269815298\u003cbr data-mce-fragment=\"1\"\u003eE-mail:\u003cspan\u003e \u003c\/span\u003e\u003ca href=\"mailto:zhangyingshi@sinopharm.com\" title=\"zhangyingshi@sinopharm.com\" data-mce-href=\"mailto:zhangyingshi@sinopharm.com\"\u003ezhangyingshi@sinopharm.com\u003c\/a\u003e\u003c\/p\u003e\n\u003ch5\u003eAdditional Information\u003c\/h5\u003e\n\u003cp\u003eSINGLE-USE HYPODERMIC SYRINGE AND NEEDLE\u003cbr\u003ePurpose: The purpose of a single-use hypodermic syringe and needle is to inject fluid into or withdraw fluid from the body for medical purposes.\u003cbr\u003eDescription: The World Bank seeks to procure single-use hypodermic syringes and needles that meet the specifications below. Single-use hypodermic syringes come in a variety of volumes and may or may not be sold as a set with a hypodermic needle. Syringes proposed shall have fixed needles and auto-disable features.\u003cbr\u003eSpecifications:\u003cbr\u003e1. Proposed syringe and needle shall be classified as a medical device and have approval by the US FDA, CE Mark or equivalent (e.g., FDA Class 2, 510(k)).\u003cbr\u003e2. Device shall be disposable and intended for single patient use.\u003cbr\u003e3. Device shall be supplied sterile and packaged in individual units.\u003cbr\u003e4. Syringe shall meet the requirements of ISO 7886-1:2017.\u003cbr\u003e5. Hypodermic needle shall meet material requirements of ISO 9626:2016.\u003cbr\u003e6. Hypodermic needle shall meet the requirements of ISO 7864:2016.\u003cbr\u003e7. Hypodermic needle shall meet the color code requirements per ISO 6009:2016.\u003cbr\u003e8. Device shall have an auto-disable feature that complies with ISO 7886-3. The syringe must be passively and automatically rendered unusable upon delivering the intended dose. It must be impossible to re-use the syringe under normal conditions of use.\u003cbr\u003e9. Syringe shall be 1ml or 3 ml in volume.\u003cbr\u003e10. Needle size shall be:\u003cbr\u003ea. Adults, 22-25 gauge with a length of 25-38mm (1-1.5”)b. Children ages 3-18, 22-25 gauge with a length of 16-25mm (5\/8 – 1”)\u003cbr data-mce-fragment=\"1\"\u003e11. Syringe shall be latex free.\u003cbr data-mce-fragment=\"1\"\u003e12. Syringe barrel must be translucent.\u003cbr data-mce-fragment=\"1\"\u003e13. Device shall be capable of being filled either directly or indirectly through a vial adapter or other transfer mechanism from a vaccine vial or ampoule, or from a needle.\u003cbr data-mce-fragment=\"1\"\u003e14. Device shall be equally useable by left and right-handed health workers.\u003cbr data-mce-fragment=\"1\"\u003e15. Syringes designed as low dead space or low dead volume are preferred.\u003c\/p\u003e\n\u003cul\u003e\u003c\/ul\u003e\n\u003col\u003e\u003c\/ol\u003e","published_at":"2021-10-22T22:15:47-04:00","created_at":"2021-10-22T22:13:22-04:00","vendor":"Sinopharm","type":"","tags":["Algeria","Angola","Antigua and Barbuda","Arab Republic of","Argentina","Bahamas","Bahrain","Bangladesh","Barbados","Belarus","Belize","Benin","Bolivia","Botswana","Brand_Sinopharm","Brazil","Brunei Darussalam","Bulgaria","Burundi","Cambodia","Cameroon","Category_Oxygen Therapy","Chile","China","Colombia","Congo","Costa Rica","Cote D'ivoire","Croatia","Cyprus","Czech Republic","Djibouti","Dominica","Dominican Republic","Ecuador","Egypt","Equatorial Guinea","Eritrea","Estonia","Ethiopia","Ghana","Grenada","Gulf Cooperation Council","Hungary","India","Indonesia","Iraq","Jamaica","Jordan","Kazakhstan","Kenya","Korea","Kuwait","Lao People's Democratic Republic","Latvia","Libya","Lithuania","Malawi","Malaysia","Malta","Mauritius","Mexico","Micronesia","Moldova","Mongolia","Morocco","Mozambique","Myanmar","Namibia","Nepal","Niger","Nigeria","Oman","Pakistan","Palau","Panama","Peru","Philippines","Poland","Product_Vaccine Consumables","Qatar","Republica Bolivariana de","Romania","Russian Federation","Rwanda","Saudi Arabia","Senegal","Serbia","Singapore","Slovak Republic","Slovenia","South Africa","Sri Lanka","St. Kitts and Nevis","St. Vincent and the Grenadines","Sudan","Suriname","Syrian Arab Republic","Tajikistan","Tanzania","Thailand","The","Timor-Leste","Tonga","Tunisia","Turkey","Tuvalu","Uganda","Ukraine","Uruguay","Uzbekistan","Vaccine Consumables","Vanuatu","Venezuela","Vietnam","Zambia"],"price":6,"price_min":6,"price_max":6,"available":true,"price_varies":false,"compare_at_price":null,"compare_at_price_min":0,"compare_at_price_max":0,"compare_at_price_varies":false,"variants":[{"id":41181270311064,"title":"Default Title","option1":"Default Title","option2":null,"option3":null,"sku":"","requires_shipping":true,"taxable":false,"featured_image":null,"available":true,"name":"Sinopharm - Single use hypodermic syringe and needle (for a la carte vaccine products)","public_title":null,"options":["Default Title"],"price":6,"weight":0,"compare_at_price":null,"inventory_management":null,"barcode":"","requires_selling_plan":false,"selling_plan_allocations":[]}],"images":["\/\/cdn.shopify.com\/s\/files\/1\/0402\/1600\/2712\/products\/Singleusehypodermicsyringeandneedle_1b6e970b-5c7c-47b8-906c-0ce5f227703c.png?v=1634955342"],"featured_image":"\/\/cdn.shopify.com\/s\/files\/1\/0402\/1600\/2712\/products\/Singleusehypodermicsyringeandneedle_1b6e970b-5c7c-47b8-906c-0ce5f227703c.png?v=1634955342","options":["Title"],"media":[{"alt":null,"id":27563969216664,"position":1,"preview_image":{"aspect_ratio":3.786,"height":70,"width":265,"src":"https:\/\/cdn.shopify.com\/s\/files\/1\/0402\/1600\/2712\/products\/Singleusehypodermicsyringeandneedle_1b6e970b-5c7c-47b8-906c-0ce5f227703c.png?v=1634955342"},"aspect_ratio":3.786,"height":70,"media_type":"image","src":"https:\/\/cdn.shopify.com\/s\/files\/1\/0402\/1600\/2712\/products\/Singleusehypodermicsyringeandneedle_1b6e970b-5c7c-47b8-906c-0ce5f227703c.png?v=1634955342","width":265}],"requires_selling_plan":false,"selling_plan_groups":[],"content":"\u003cul\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eProduct ID\u003c\/b\u003e: VC.25.2\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLead Time (from Signed Agreement):\u003c\/strong\u003e 30 days. \u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMinimum Order Quantity\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e- 500,000. \u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRegulatory approval:\u003c\/strong\u003e\u003cspan\u003e WHO PQS\u003c\/span\u003e, CE Mark\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAuto disable feature:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eYes\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeedle Length:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e25 mm\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeedle Gauge:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e25g\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSyringe Volume:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e1 ml\/1cc\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSterile:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eYes\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLow dead space:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eYes\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuantity per box\u003c\/strong\u003e: 100\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrice:\u003c\/strong\u003e per syringe\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\u003c\/ul\u003e\n\u003c!-- TABS --\u003e\n\u003ch5\u003eProduct Details\u003c\/h5\u003e\n\u003ch6\u003eInspection\u003c\/h6\u003e\n\u003cp\u003eA factory audit and final random inspection and testing of finished products will be performed by a Bank nominated independent inspection agency. The inspection contract will be let by Sinopharm to the approved inspection agency with costs passed through to the Borrower to pay.\u003c\/p\u003e\n\u003ch6\u003e\u003c\/h6\u003e\n\u003ch5\u003eAbout \u0026amp; Contact\u003cbr\u003e\n\u003c\/h5\u003e\n\u003ch6\u003e\u003c\/h6\u003e\n\u003cp\u003e\u003cspan data-contrast=\"none\" class=\"TextRun BCX9 SCXW139326093\" lang=\"EN-NZ\" xml:lang=\"EN-NZ\"\u003e\u003cspan class=\"NormalTextRun BCX9 SCXW139326093\"\u003e\u003cspan\u003eChina National Pharmaceutical Group Co., Ltd. (Sinopharm) is a large healthcare group directly under the State-owned Assets Supervision and Administration Commission (SASAC) of the State Council, with 128,000 employees and a full chain in the industry covering R\u0026amp;D, manufacturing, logistics and distribution, retail chains, healthcare, engineering services, exhibitions and conferences, international business and financial services.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eFor further enquiries, please contact \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eJade Zhang\u003c\/strong\u003e\u003cbr data-mce-fragment=\"1\"\u003e\u003cspan data-mce-fragment=\"1\"\u003eSinopharm Fortune International Trading Corp.\u003c\/span\u003e\u003cbr data-mce-fragment=\"1\"\u003eAddress: Fortune Tower, No.4, Hui Xin Dongjie, Chao Yang District, Beijing 100029, China\u003cbr data-mce-fragment=\"1\"\u003eTel.: +86-10-8466 3076\/ +86-13269815298\u003cbr data-mce-fragment=\"1\"\u003eE-mail:\u003cspan\u003e \u003c\/span\u003e\u003ca href=\"mailto:zhangyingshi@sinopharm.com\" title=\"zhangyingshi@sinopharm.com\" data-mce-href=\"mailto:zhangyingshi@sinopharm.com\"\u003ezhangyingshi@sinopharm.com\u003c\/a\u003e\u003c\/p\u003e\n\u003ch5\u003eAdditional Information\u003c\/h5\u003e\n\u003cp\u003eSINGLE-USE HYPODERMIC SYRINGE AND NEEDLE\u003cbr\u003ePurpose: The purpose of a single-use hypodermic syringe and needle is to inject fluid into or withdraw fluid from the body for medical purposes.\u003cbr\u003eDescription: The World Bank seeks to procure single-use hypodermic syringes and needles that meet the specifications below. Single-use hypodermic syringes come in a variety of volumes and may or may not be sold as a set with a hypodermic needle. Syringes proposed shall have fixed needles and auto-disable features.\u003cbr\u003eSpecifications:\u003cbr\u003e1. Proposed syringe and needle shall be classified as a medical device and have approval by the US FDA, CE Mark or equivalent (e.g., FDA Class 2, 510(k)).\u003cbr\u003e2. Device shall be disposable and intended for single patient use.\u003cbr\u003e3. Device shall be supplied sterile and packaged in individual units.\u003cbr\u003e4. Syringe shall meet the requirements of ISO 7886-1:2017.\u003cbr\u003e5. Hypodermic needle shall meet material requirements of ISO 9626:2016.\u003cbr\u003e6. Hypodermic needle shall meet the requirements of ISO 7864:2016.\u003cbr\u003e7. Hypodermic needle shall meet the color code requirements per ISO 6009:2016.\u003cbr\u003e8. Device shall have an auto-disable feature that complies with ISO 7886-3. The syringe must be passively and automatically rendered unusable upon delivering the intended dose. It must be impossible to re-use the syringe under normal conditions of use.\u003cbr\u003e9. Syringe shall be 1ml or 3 ml in volume.\u003cbr\u003e10. Needle size shall be:\u003cbr\u003ea. Adults, 22-25 gauge with a length of 25-38mm (1-1.5”)b. Children ages 3-18, 22-25 gauge with a length of 16-25mm (5\/8 – 1”)\u003cbr data-mce-fragment=\"1\"\u003e11. Syringe shall be latex free.\u003cbr data-mce-fragment=\"1\"\u003e12. Syringe barrel must be translucent.\u003cbr data-mce-fragment=\"1\"\u003e13. Device shall be capable of being filled either directly or indirectly through a vial adapter or other transfer mechanism from a vaccine vial or ampoule, or from a needle.\u003cbr data-mce-fragment=\"1\"\u003e14. Device shall be equally useable by left and right-handed health workers.\u003cbr data-mce-fragment=\"1\"\u003e15. Syringes designed as low dead space or low dead volume are preferred.\u003c\/p\u003e\n\u003cul\u003e\u003c\/ul\u003e\n\u003col\u003e\u003c\/ol\u003e"}

Sinopharm - Single use hypodermic syringe and needle (for a la carte vaccine products)

Product Description
    • Product ID: VC.25.2
    • Lead Time (from Signed Agreement): 30 days. 
    • Minimum Order Quantity - 500,000. 
    • Regulatory approval: WHO PQS, CE Mark
    • Auto disable feature: Yes
    • Needle Length: 25 mm
    • Needle Gauge: 25g
    • Syringe Volume: 1 ml/1cc
    • Sterile: Yes
    • Low dead space: Yes
    • Quantity per box: 100
    • Price: per syringe
    Log in to purchase
    Maximum quantity available reached.
    Inspection

    A factory audit and final random inspection and testing of finished products will be performed by a Bank nominated independent inspection agency. The inspection contract will be let by Sinopharm to the approved inspection agency with costs passed through to the Borrower to pay.

    China National Pharmaceutical Group Co., Ltd. (Sinopharm) is a large healthcare group directly under the State-owned Assets Supervision and Administration Commission (SASAC) of the State Council, with 128,000 employees and a full chain in the industry covering R&D, manufacturing, logistics and distribution, retail chains, healthcare, engineering services, exhibitions and conferences, international business and financial services.

    For further enquiries, please contact 

    Jade Zhang
    Sinopharm Fortune International Trading Corp.
    Address: Fortune Tower, No.4, Hui Xin Dongjie, Chao Yang District, Beijing 100029, China
    Tel.: +86-10-8466 3076/ +86-13269815298
    E-mail: zhangyingshi@sinopharm.com

    SINGLE-USE HYPODERMIC SYRINGE AND NEEDLE
    Purpose: The purpose of a single-use hypodermic syringe and needle is to inject fluid into or withdraw fluid from the body for medical purposes.
    Description: The World Bank seeks to procure single-use hypodermic syringes and needles that meet the specifications below. Single-use hypodermic syringes come in a variety of volumes and may or may not be sold as a set with a hypodermic needle. Syringes proposed shall have fixed needles and auto-disable features.
    Specifications:
    1. Proposed syringe and needle shall be classified as a medical device and have approval by the US FDA, CE Mark or equivalent (e.g., FDA Class 2, 510(k)).
    2. Device shall be disposable and intended for single patient use.
    3. Device shall be supplied sterile and packaged in individual units.
    4. Syringe shall meet the requirements of ISO 7886-1:2017.
    5. Hypodermic needle shall meet material requirements of ISO 9626:2016.
    6. Hypodermic needle shall meet the requirements of ISO 7864:2016.
    7. Hypodermic needle shall meet the color code requirements per ISO 6009:2016.
    8. Device shall have an auto-disable feature that complies with ISO 7886-3. The syringe must be passively and automatically rendered unusable upon delivering the intended dose. It must be impossible to re-use the syringe under normal conditions of use.
    9. Syringe shall be 1ml or 3 ml in volume.
    10. Needle size shall be:
    a. Adults, 22-25 gauge with a length of 25-38mm (1-1.5”)b. Children ages 3-18, 22-25 gauge with a length of 16-25mm (5/8 – 1”)
    11. Syringe shall be latex free.
    12. Syringe barrel must be translucent.
    13. Device shall be capable of being filled either directly or indirectly through a vial adapter or other transfer mechanism from a vaccine vial or ampoule, or from a needle.
    14. Device shall be equally useable by left and right-handed health workers.
    15. Syringes designed as low dead space or low dead volume are preferred.